A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64B after a jury found it liable in a whistleblower lawsuit for illegally promoting the HIV drugs Prezista and Intelence, Reuters’ Jonathan Stempel reports. U.S. District Judge Zahid Quraishi in Trenton, New Jersey, ordered the drugmaker’s Janssen unit to pay $360M for violating the federal False Claims Act. He also imposed $1.28B in civil fines, or $8,000 for each of 159,574 false claims the jury found were submitted to programs such as Medicare, Medicaid and the AIDS Drug Assistance Program. Johnson & Johnson, based in New Brunswick, New Jersey, said it is confident the verdict will be reversed on appeal, the author notes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- JNJ Unit Ordered to Cough Up $1.64B for Illegal Promotion of HIV Drugs
- Healthcare Stocks Sicken as RFK JR Cuts Thousands of Jobs at Health Department
- RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
- AnaptysBio could have positive read from J&J abstracts, says Guggenheim
- J&J says Rybrevant/Lazcluze outperforms osimertinib OS in Phase 3 study